Table

Table 1

Table 1: Prevalence of HBV in HIV infected patients from Durban, KwaZulu-Natal, South Africa.
Characteristic N Overall, N = 501 HBV DNA p-value2
Negative, N = 91 Positive, N = 411
Age 50 34 (26, 39) 35 (33, 41) 32 (24, 39) 0.3
Age_group 49 0.5
< 19 3 (6.1%) 1 (11%) 2 (5.0%)
20-29 15 (31%) 1 (11%) 14 (35%)
30-39 19 (39%) 4 (44%) 15 (38%)
40-49 9 (18%) 2 (22%) 7 (18%)
50-59 3 (6.1%) 1 (11%) 2 (5.0%)
HIV-1 50
Positive 50 (100%) 9 (100%) 41 (100%)
HBsAg 50
Positive 50 (100%) 9 (100%) 41 (100%)
Genotype 50 <0.001
A 43 (86%) 2 (22%) 41 (100%)
None 7 (14%) 7 (78%) 0 (0%)
Sub Genotypes 50 <0.001
A1 39 (78%) 2 (22%) 37 (90%)
A2 4 (8.0%) 0 (0%) 4 (9.8%)
None 7 (14%) 7 (78%) 0 (0%)
RT mutations 50 9 (6, 12) 0 (0, 0) 10 (7, 13) <0.001
SHB protein 50 6.0 (3.0, 7.0) 0.0 (0.0, 0.0) 6.0 (4.0, 8.0) <0.001
Lamivudine 50 <0.001
No sequence 8 (16%) 7 (78%) 1 (2.4%)
Resistant 6 (12%) 1 (11%) 5 (12%)
Susceptible 36 (72%) 1 (11%) 35 (85%)
Adefovir 50 <0.001
No sequence 8 (16%) 7 (78%) 1 (2.4%)
Resistant 1 (2.0%) 0 (0%) 1 (2.4%)
Susceptible 41 (82%) 2 (22%) 39 (95%)
Entecavir 50 <0.001
No sequence 8 (16%) 7 (78%) 1 (2.4%)
Resistant 6 (12%) 0 (0%) 6 (15%)
Susceptible 36 (72%) 2 (22%) 34 (83%)
Tenofovir 50 <0.001
No sequence 8 (16%) 7 (78%) 1 (2.4%)
Susceptible 42 (84%) 2 (22%) 40 (98%)
Telbivudine 50 <0.001
No sequence 8 (16%) 7 (78%) 1 (2.4%)
Resistant 4 (8.0%) 0 (0%) 4 (9.8%)
Susceptible 38 (76%) 2 (22%) 36 (88%)

1 Median (IQR); n (%)

2 Wilcoxon rank sum test; Fisher's exact test

Graphs

Graph 1

Graph 2

Graph 3

Graph 4

Graph 5

Graph 6

Correlation Analysis

Graph 1

Graph 2

Graph 3

Graph 4